The antinociceptive effect of α2δ ligands is not surprising given that these drugs are frequently used in the treatment of chronic pain, mainly neuropathic (Verma et al., 2014) but also in fibromyalgia (Traynor et al., 2011). The gene discussed is ATXN2L; the disease is fibromyalgia.